Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Pernix Therapeutics Holdings Inc (PTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7104
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR) opioid agonist that is indicated for pain severe management, and long-term opioid treatment; a non-narcotic, non-addictive, and non-scheduled prescription sleep aid to treat insomnia; an antibiotic for infections of middle ear; and indications for depressive disorder in adults. Its branded and generic pharmaceuticals products span the therapeutic areas of neurology, psychiatry, and pain management. The company serves drug wholesalers, retail drug stores, and mass merchandisers. It has subsidiaries in the US and Ireland. Pernix Therapeutics is headquartered in Morristown, New Jersey, the US.

Pernix Therapeutics Holdings Inc (PTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pernix Therapeutics Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pernix Therapeutics Holdings Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Pernix Therapeutics Plans to Raise up to USD50 Million in Public Offering of Shares 10
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 11
Debt Offering 12
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 12
Pernix Therapeutics Holdings Raises USD65 Million in Private Palcement of 8% Notes Due 2019 14
Pernix Therapeutics Holdings Raises USD220 Million in Private Placement of Notes 15
Acquisition 16
Pernix Therapeutics May Sell Itself 16
Pernix Therapeutics Holdings Inc – Key Competitors 17
Pernix Therapeutics Holdings Inc – Key Employees 18
Pernix Therapeutics Holdings Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 09, 2018: Pernix Therapeutics reports second quarter 2018 financial results 20
May 10, 2018: Pernix Therapeutics Reports First Quarter 2018 Financial Results 23
Mar 08, 2018: Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results 24
Nov 07, 2017: Pernix Therapeutics Reports Third Quarter 2017 Financial Results 27
Jul 27, 2017: Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update 30
Jul 20, 2017: Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results 33
May 15, 2017: Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update 35
Mar 28, 2017: Pernix Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results 37
Corporate Communications 41
Feb 06, 2018: Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion 41
Nov 16, 2017: Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors 42
Oct 17, 2017: Pernix Therapeutics Announces Planned Departure of Chief Financial Officer 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Pernix Therapeutics Holdings Inc, Medical Equipment, Key Facts, 2017 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pernix Therapeutics Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pernix Therapeutics Holdings Inc, Deals By Market, 2012 to YTD 2018 8
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pernix Therapeutics Plans to Raise up to USD50 Million in Public Offering of Shares 10
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 11
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 12
Pernix Therapeutics Holdings Raises USD65 Million in Private Palcement of 8% Notes Due 2019 14
Pernix Therapeutics Holdings Raises USD220 Million in Private Placement of Notes 15
Pernix Therapeutics May Sell Itself 16
Pernix Therapeutics Holdings Inc, Key Competitors 17
Pernix Therapeutics Holdings Inc, Key Employees 18
Pernix Therapeutics Holdings Inc, Subsidiaries 19

List of Figures
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gemini Corp (GKX)-石油・ガス分野:企業M&A・提携分析
    Summary Gemini Corporation (Gemini) is an oil and gas engineering company that provides engineering, field and environmental solutions. The company offers services including project management systems, fabrication, maintenance, procurement, construction, land, environmental, regulatory, and reclamat …
  • Celmatix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Celmatix Inc (Celmatix) is a medicine company that develops infertility treatment products. The company provides products such as Polaris, an analytics platform for optimizing a woman’s fertility; and Fertilome test is a next generation sequencing panel that reveals genetic factors significa …
  • Arla Foods UK Plc:企業の戦略・SWOT・財務情報
    Arla Foods UK Plc - Strategy, SWOT and Corporate Finance Report Summary Arla Foods UK Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CMS Energy Corp (CMS):企業の財務・戦略的SWOT分析
    CMS Energy Corp (CMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • J.F. Shea Co Inc:企業の戦略・SWOT・財務分析
    J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report Summary J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tellurian Inc (TELL):石油・ガス:M&Aディール及び事業提携情報
    Summary Tellurian Inc (Tellurian), formerly Magellan Petroleum Corp, is an oil and gas company that provides exploration, development, and production of crude oil and natural gas. The company develops liquefied natural gas production and export terminal on the west bank of the Calcasieu River, south …
  • Austrian Post:企業の戦略・SWOT・財務情報
    Austrian Post - Strategy, SWOT and Corporate Finance Report Summary Austrian Post - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Canon Medical Systems Corp:医療機器:M&Aディール及び事業提携情報
    Summary Canon Medical Systems Corp (Canon Medical Systems), formerly known as Toshiba Medical Systems Corp, a subsidiary of Canon Inc, is a provider of medical diagnostic systems and comprehensive medical solutions. The company’s product portfolio include computed tomography systems, magnetic resona …
  • High Peak Royalties Ltd (HPR):石油・ガス:M&Aディール及び事業提携情報
    Summary High Peak Royalties Limited (High Peak) is a leading utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The compa …
  • Attica Bank S.A.:企業の戦略・SWOT・財務分析
    Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report Summary Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hutchison Telecommunications (Australia) Limited (HTA):企業の財務・戦略的SWOT分析
    Hutchison Telecommunications (Australia) Limited (HTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • EPS Holdings Inc (4282):製薬・医療:M&Aディール及び事業提携情報
    Summary EPS Holdings Inc (EPS) is a pharmaceutical solutions provider to the healthcare industry. The company provides contract research organization, site management organization, contract sales organization, and other related services for pharmaceutical and medical device development. Its services …
  • Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that focuses on the development of therapies through its proprietary Medici Drug Delivery System, a subcutaneous delivery system to treat chronic conditions. The company’s product candidate includ …
  • SBI Holdings Inc (8473):企業の財務・戦略的SWOT分析
    SBI Holdings Inc (8473) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Tokuyama Corporation (4043)-エネルギー分野:企業M&A・提携分析
    Summary Tokuyama Corporation (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, me …
  • Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly Arrowhead Research Corp, is a pharmaceutical company that develops and markets medicinal products. The company develops pipeline drugs that are being developed to treat chronic hepatitis B virus infection for the treatment of liver disease, …
  • Universal Electronics Inc (UEIC):企業の財務・戦略的SWOT分析
    Summary Universal Electronics Inc (Universal Electronics) is a technology company that offers control and sensor technology solutions. The company offers a range of pre-programmed and universal remote control products, audio-video accessories, intelligent wireless security and automation components, …
  • Gokul Refoils & Solvent Ltd. (GOKUL):企業の財務・戦略的SWOT分析
    Gokul Refoils & Solvent Ltd. (GOKUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • CohBar Inc (CWBR):製薬・医療:M&Aディール及び事業提携情報
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • China Resources Zizhu Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Zizhu Pharmaceutical Co Ltd (Zizhu Pharmaceutical) is a provider of pharmaceutical development, manufacture, and marketing programs. The company offers dietary supplements, women healthcare products, ophthalmology medicines, APIs and intermediates, anesthetic, biological agen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆